SUSCEPTIBILITIES OF NONTUBERCULOSIS MYCOBACTERIAL SPECIES TO AMOXICILLIN-CLAVULANIC ACID ALONE AND IN COMBINATION WITH ANTIMYCOBACTERIAL AGENTS

被引:12
作者
UTRUP, LJ
MOORE, TD
ACTOR, P
POUPARD, JA
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
[2] PAUL ACTOR ASSOCIATES,PHOENIXVILLE,PA
关键词
D O I
10.1128/AAC.39.7.1454
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Neither amoxicillin nor clavulanic acid used alone was active at the highest level tested, i.e., 256.0 mu g/ml, in vitro against 24 isolates of Mycobacterium fortuitum, Mycobacterium kansasii, and Mycobacterium marinum, However, the MIC of an amoxicillin-clavulanic acid combination of 2:1 was less than or equal to 8.0/4.0 mu g/ml for 50 percent of the isolates tested, with all isolates being inhibited in the range of 4.0/2.0 to 32.0/16.0 mu g/ml, respectively, Titration of amoxicillin-clavulanic acid with a fixed 2-mu g/ml concentration of ethambutol resulted in synergistic activity against 3 of 9 isolates of M. fortuitum, 10 of 10 isolates of M. kansnsii, and 5 of 5 isolates of M. marinum, This observation was confirmed in a checkerboard analysis in which fractional inhibitory concentrations were less than or equal to 0.5 for 20 of the 24 isolates, Synergistic activity was observed against the other four isolates in one of two trials, On the other hand, titration of amoxicillin-clavulanic acid in the presence of either one or two fixed concentrations of isoniazid, rifampin, cycloserine, tetracycline, or amikacin failed to result in synergism.
引用
收藏
页码:1454 / 1457
页数:4
相关论文
共 33 条
[1]   CHARACTERIZATION OF A BETA-LACTAMASE PRODUCED IN MYCOBACTERIUM-FORTUITUM D316 [J].
AMICOSANTE, G ;
FRANCESCHINI, N ;
SEGATORE, B ;
ORATORE, A ;
FATTORINI, L ;
OREFICI, G ;
VANBEEUMEN, J ;
FRERE, JM .
BIOCHEMICAL JOURNAL, 1990, 271 (03) :729-734
[2]  
BARTMANN K, 1988, HDB EXPT PHARM, V84, P259
[3]  
BHATTACHARYA CP, 1988, INDIAN J MED RES, V88, P118
[4]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[5]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO AUGMENTIN [J].
CASAL, M ;
RODRIGUEZ, F ;
BENAVENTE, M ;
LUNA, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :453-454
[6]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AFRICANUM, MYCOBACTERIUM-BOVIS, MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-FORTUITUM, AND MYCOBACTERIUM-CHELONAE TO TICARCILLIN IN COMBINATION WITH CLAVULANIC ACID [J].
CASAL, MJ ;
RODRIGUEZ, FC ;
LUNA, MD ;
BENAVENTE, MC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :132-133
[7]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-FORTUITUM TO AMOXICILLIN OR CEPHALOTHIN IN COMBINATION WITH CLAVULANIC ACID [J].
CYNAMON, MH ;
PALMER, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (06) :935-937
[8]   INVITRO ACTIVITY OF AMOXICILLIN IN COMBINATION WITH CLAVULANIC ACID AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
CYNAMON, MH ;
PALMER, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :429-431
[9]   RECOGNITION OF MULTIPLE EFFECTS OF ETHAMBUTOL ON METABOLISM OF MYCOBACTERIAL CELL-ENVELOPE [J].
DENG, LY ;
MIKUSOVA, K ;
ROBUCK, KG ;
SCHERMAN, M ;
BRENNAN, PJ ;
MCNEIL, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :694-701
[10]  
ELIOPOULOS GM, 1992, ANTIBIOTICS LAB MED, P432